Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Tecentriq Plus Avastin, Chemo Hit Goal in Extensive-Stage SCLC
October 25, 2023
- Ono, Turbine Ink Research Collab in Hunt for Oncology Targets
October 25, 2023
- Prostate Cancer Med Orgovyx Approved in Canada: Sumitomo
October 25, 2023
- Sawai Fudged Quality Tests of Gastritis Drug for 8 Years, Awaiting Penalty Decision
October 24, 2023
- Janssen Files PAH Fixed-Dose Combo Drug in Japan
October 24, 2023
- Enhertu Gets EU Nod for NSCLC, Triggers US$75 Million Milestone
October 24, 2023
- Pfizer Japan Recalling Docetaxel IV Infusion 20 mg/2 mL
October 23, 2023
- Daiichi Sankyo, Merck in Global ADC Deal Worth Up to US$22 Billion
October 23, 2023
- Myfembree Gets Canada Nod for Uterine Fibroid, Endometriosis
October 23, 2023
- Takeda’s Adcetris Approved in Europe for 7th Indication
October 23, 2023
- Medicon, Mucodyne among Drugs Subject to MHLW’s Ramp-Up Request
October 20, 2023
- Oncology, Cell & Gene Therapies Key Priorities for Bayer Co.Labs: Global Head
October 20, 2023
- Kyowa Kirin Set to Gain Tens of Billions of Yen in Sales from Orchard Acquisition
October 20, 2023
- Takeda to Pay 130 Million Euro to Settle Tax Row over Shire-AbbVie Breakup Fee
October 19, 2023
- Takeda’s 1st Cell Therapy Alofisel Misses Goal in Key PIII Study
October 19, 2023
- Diazepam Nasal Spray Shows Efficacy in PIII Interim Analysis: Aculys
October 19, 2023
- Fuji Pharma/M3’s Dysmenorrhea Drug Filed in Japan, 2024 Rollout Targeted
October 19, 2023
- Herceptin Biosimilars Get Colorectal Cancer Nod: Celltrion, Nippon Kayaku
October 19, 2023
- Daiichi Sankyo Ordered to Pay 8% Royalty to Seagen in ADC Patent Row
October 19, 2023
- BMS Looks to Double Japan Biz in Next 10 Years with Partnership as a Pillar
October 19, 2023
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…